Skip to main content
Healthcare

STAT+: FDA approves new breast cancer drug, providing new option for some patients, boost for Roche

STAT+: FDA approves new breast cancer drug, providing new option for some patients, boost for Roche

Feed excerpt — reported by STAT News

The FDA approved a new breast cancer drug from Roche, teeing up the launch of a medicine the company has said could become its top-selling product ever.

MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at STAT News →

Original Source

This article was syndicated from STAT News. All rights remain with the original publisher.